## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%); PEG 2.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Swedbank AB Has $766.67 Million Stock Holdings in Xylem Inc. $XYL**
- Source: MarketBeat | 20251224T135454 | Bullish | Relevance: 100%
- Swedbank AB significantly increased its stake in Xylem Inc. (NYSE:XYL) by 19% in the third quarter, now holding over 5.19 million shares valued at approximately $766.67 million, making it their 19th largest holding. Xylem reported strong Q3 earnings, surpassing analyst expectations with $1.37 EPS and $2.27 billion in revenue, and maintains a "Moderate Buy" consensus rating from analysts. The article also details recent insider transactions and analyst rating changes for Xylem.

**2. Investors Appear Satisfied With Xylem Inc.'s (NYSE:XYL) Prospects**
- Source: Simply Wall Street | 20251223T104043 | Bullish | Relevance: 100%
- Xylem Inc.'s high P/E ratio of 35.7x, compared to a market average of under 19x, suggests strong investor confidence. This confidence is driven by the company's superior earnings growth, with a 14% gain last year and a 120% rise over three years, plus analyst forecasts of 15% annual growth, exceeding the market's predicted 11%. Shareholders seem to anticipate continued prosperity, underpinning the elevated P/E ratio.

**3. Xylem outlook revised to positive by S&P on solid credit metrics By Investing.com**
- Source: Investing.com Nigeria | 20251222T220905 | Bullish | Relevance: 100%
- S&P Global Ratings has revised its outlook on Xylem Inc. to positive from stable, affirming its 'BBB' credit rating, due to strong credit metrics and anticipated long-term adjusted leverage of 1.5x-2x. The rating agency expects Xylem to maintain this leverage despite potential acquisitions, with management prioritizing debt reduction. S&P projects solid organic revenue growth, supported by demand for clean water solutions and a robust backlog, alongside improving EBITDA margins and free operating cash flow.

**4. Xylem outlook revised to positive by S&P on solid credit metrics**
- Source: Investing.com UK | 20251222T220833 | Bullish | Relevance: 100%
- S&P Global Ratings has revised its outlook on Xylem Inc. to positive from stable, while affirming its 'BBB' credit rating, anticipating the company will maintain adjusted leverage of 1.5x-2x over the long term. This positive revision is driven by strong organic revenue growth projections, a solid backlog, and expected improvements in EBITDA margins and free operating cash flow. S&P expects Xylem to continue strategic bolt-on acquisitions but prioritizes debt reduction to maintain healthy leverage ratios.

**5. Xylem outlook revised to positive by S&P on solid credit metrics**
- Source: Investing.com | 20251222T222057 | Bullish | Relevance: 98%
- S&P Global Ratings has revised its outlook on Xylem Inc. from stable to positive, affirming its 'BBB' credit rating, due to expectations that Xylem will maintain adjusted leverage of 1.5x-2x long-term. This positive outlook is supported by projected organic revenue growth of 4% annually, driven by demand for clean water solutions and infrastructure investment, and a solid $5 billion backlog. S&P anticipates Xylem will pursue acquisitions and prioritize debt reduction to maintain leverage within the target range.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.11 elevated, pricing in significant growth expectations. Forward P/E 24.9x stretched relative to 10% growth. Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.8B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.11 |
| Forward P/E | 24.9 |
| Current P/E | 27.4 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.4% to -1.1% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). RSI neutral at 45. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.10% (CS: 48) | Neutral |
| RSI_14 | 45.1 | Neutral |
| MACD Histogram | 0.34 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 1.037x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.69
- **Stop Loss:** $134.23 (3.2% risk)
- **Target:** $143.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 201
- **Position Value:** $27,876.69
- **Portfolio %:** 27.88%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*